The quantitative assessment of the WT1 gene transcript has been utilized as a marker of MRD in AML after induction and consolidation7,9 and can be a predictor of relapse.23 Data of WT1 as a marker of the presence of MRD are scarce and contradictory. Here, WT1 is linked to acute myeloid leukemia.